Evidence map›Paper›PMID 35458181›Full record

Trial reportNutrients2022

Blueberry Supplementation in Midlife for Dementia Risk Reduction.

Robert Krikorian, Matthew R Skelton, Suzanne S Summer, Marcelle D Shidler, Patrick G Sullivan

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 41 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 7 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06735599 narecruitingnot on this mapstarted 2024, after this paper: background citation

Effects of Wild Blueberry Consumption on Gut, Brain, and Cardiovascular Health in Non-Hispanic Black and White Adults With High Blood Pressure

TypeinterventionalSponsorGeorgia State UniversityRan2024 to 2027Enrolled40ConditionsHypertension (Without Type 2 Diabetes Mellitus), High Blood Pressure, Male, FemaleArmsWild Blueberry, Placebo
NCT06735651 narecruitingnot on this mapstarted 2024, after this paper: background citation

Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Female Adults With Prediabetes.

TypeinterventionalSponsorGeorgia State UniversityRan2024 to 2026Enrolled30ConditionsPrediabetes (Insulin Resistance, Impaired Glucose Tolerance), Female, Adult, Endothelial Function (Reactive Hyperemia)ArmsWild Blueberry, Placebo
3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 7 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Robert KrikorianDepartment of Psychiatry & Behavioral Neuroscience, University of Cincinnati Academic Health Center, Cincinnati, OH 45267, USA.
Matthew R SkeltonDivision of Neurology, Cincinnati Children's Research Foundation, Cincinnati, OH 45229, USA.
Suzanne S SummerBionutrition Core, Clinical Translational Research Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Marcelle D ShidlerDepartment of Psychiatry & Behavioral Neuroscience, University of Cincinnati Academic Health Center, Cincinnati, OH 45267, USA.
Patrick G SullivanSpinal Cord & Brain Injury Research Center, Chandler College of Medicine, University of Kentucky, Lexington, KY 40506, USA.ORCID 0000-0001-7418-4760
Cincinnati Children's Hospital Medical Center · USUniversity of Cincinnati Medical Center · USUniversity of Kentucky · US

Funding

Using a ketogenic diet to treat creatine transporter deficiencyR21NS111217 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI SKELTON, MATTHEW R · 2019 to 2019
$437k
NINDS NIH HHS R21 NS111217
6 · The paper itself

Abstract

Late-life dementia typically develops over a period of many years beginning in midlife. Prevalence of metabolic disturbance also accelerates in middle age and is a prominent risk factor for dementia. Preliminary studies indicate that blueberry supplementation can improve cognitive performance and influence metabolism and brain function and therefore may have a role in early intervention to prevent neurodegeneration. In a randomized controlled trial, we investigated the effects of daily blueberry supplementation in a middle-aged sample of insulin-resistant participants with elevated risk for future dementia. We enrolled overweight men and women, aged 50 to 65 years, with subjective cognitive decline (SCD) and performed pre- and post-intervention assessments of cognition and metabolism and exploratory measures of peripheral mitochondrial function. We observed improved performances for the blueberry group on measures of lexical access,

Indexed as

Blueberry PlantsCognitive DysfunctionDementiaCognitionDietary SupplementsFemaleHumansMaleMiddle AgedRisk Reduction BehaviorBMIcognitioninsulin resistance

Identifiers

PMID35458181
PMCPMC9031005
OpenAlexW4223998421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.